Universe Pharmaceuticals Inc. (UPC) NASDAQ
3.38
+0.0105(+0.31%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 14,607.6 |
| Enterprise Value | -24.32M |
| P/E Ratio | -0.52 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.11 |
| Price/Book Ratio | 0.03 |
| Enterprise/Revenue | -1.26 |
| Enterprise/EBITDA | 7.67 |
Fiscal Year
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | -0.21 |
| Operating Margin | -0.16 |
Management Effectiveness
| Return On Assets | -0.05 |
| Return On Equity | -0.07 |
Income Statement
| Revenue | 17.86M |
| Revenue/Share | 31.7 |
| Gross Profit | 6.3M |
| EBITDA | -2.92M |
| Net Income | -3.67M |
| Diluted EPS | -1,055.75 |
Balance Sheet
| Total Cash | 33.59M |
| Total Cash/Share | 59.63 |
| Total Debt | 9.26M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 4.07 |
| Book Value Per Share | 99.64 |
Price History
| 52-Week Change | -30.01 |
| 52-Week High | 11 |
| 52-Week Low | 2 |
| Moving Average 50 Days | 2.94 |
| Moving Average 200 Days | 3.72 |
Statistics
| Average Volume | 8,717 |
| Shares Outstanding | 563,338 |
| % Held by Institutions | 27.2 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | March 24, 2025 |
